Let's talk about how our products can help your research and therapeutic development.
Selective Early Access to Synthego mRNA CRISPR Editors. Learn how Synthego's mRNA Pilot Validation Program gives researchers early access to next-generation CRISPR editors while providing insight into the manufacturing platform...
Gene editing programs move beyond proving CRISPR works to determining whether it can scale. Delivery strategy shapes everything from manufacturing complexity to cost and clinical feasibility, and while viral vectors...
The FDA's new "plausible mechanism pathway," born from a groundbreaking bespoke CRISPR therapy case, signals a paradigm shift for complex biologics and personalized medicine. While this framework aims to streamline...